{ }
Very Negative
Negative
Neutral
Positive
Very Positive
2025-04-112025-04-112025-04-132025-04-1311133221100
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-04-112025-04-112025-04-132025-04-1311133221100
Download SVG
Download PNG
Download CSV

ubs asset management strengthens market position through credit suisse integration

Francesca Prym, CEO of UBS Asset Management Europe, highlighted Luxembourg's strategic importance following the successful merger of Credit Suisse Fund Management and UBS Fund Management in October 2024. The integration has positioned UBS AM among the top three fund management companies in Luxembourg, optimizing operations and enhancing market presence. Prym emphasized the need for agility in response to evolving European regulations and the firm's commitment to diversity and inclusion within its workforce.

barclays lowers dow inc price target to thirty eight dollars

Barclays has lowered its price target for Dow Inc. to $38 from $44 while maintaining an equal-weight rating. Dow specializes in manufacturing and marketing a range of products, with net sales primarily from basic plastics (50.7%), elaborate plastics (27.6%), and performance chemicals (20%). Geographically, sales are distributed across the U.S. and Canada (38.2%), Europe/Middle East/Africa/India (32.5%), Asia/Pacific (17.9%), and Latin America (11.4%).

Northvolt reduces workforce to 1700 amid bankruptcy and asset sale efforts

Swedish battery manufacturer Northvolt AB is in bankruptcy, reducing its workforce from 7,000 to 1,700 employees as it scales back operations. Bankruptcy trustee Mikael Kubu stated that limited operations are essential for a potential sale, with the company's assets currently up for sale under court direction. Despite raising around US$10 billion since its founding in 2016, Northvolt has faced significant operational challenges and rising liabilities, resulting in substantial losses for stakeholders.

huawei reports 28 percent profit drop despite 22 percent revenue surge

Huawei Technologies reported a 28% drop in net profit to 62.6 billion yuan ($8.6 billion) in 2024, despite a 22% revenue increase to $118.2 billion, driven by strong sales in consumer goods and automotive services. The profit decline was attributed to increased investments in advanced technologies and a lack of business sales gains. The company spent over 179.7 billion yuan (nearly $25 billion) on R&D, employing more than half of its workforce in this area, while facing challenges from U.S. trade restrictions and security concerns.

Pernod Ricard maintains strong market position in premium wines and spirits

Pernod Ricard, the leading producer of premium wines and spirits, reported that 61.8% of its sales come from strategic international brands, with Absolut and Jameson being top sellers. The company operates 94 production sites globally, with sales distributed across Europe (28.3%), the Americas (28.8%), and other regions (42.9%).

hive digital technologies faces challenges with expected negative earnings per share

HIVE Digital Technologies Ltd., a cryptocurrency mining company operating in Canada, Sweden, and Iceland, is projected to report a -0.32 EPS for the current year. Despite a Buy rating from analysts, top-rated experts suggest five other stocks are better investment options. Recently, Charles Schwab Investment Management increased its holdings in HIVE by 126.4%, now owning about 0.50% of the company. HIVE's shares opened at $1.50, with a market cap of $237.14 million, and analysts have set an average price target of $7.64.

Ionis Pharmaceuticals maintains focus on Tryngolza launch amid mixed analyst ratings

UBS analyst Esther Rajavelu has maintained a Neutral rating on Ionis Pharmaceuticals with a price target of $45, as the stock trades near its 52-week low at $31.40. The company is focused on launching Tryngolza for familial chylomicronemia syndrome and has partnered with Sobi for commercialization outside the U.S. Despite a revenue decline of 10.5% to $705 million, Ionis has secured EU approval for WAINZUA and is advancing its investigational treatments, while management anticipates Phase 3 data for olezarsen in severe hypertriglyceridemia by late 2025.

Regula Berger appointed new chairwoman of Bank Cler Board of Directors

Regula Berger has been appointed as the new Chairwoman of the Board of Directors at Bank Cler, succeeding Basil Heeb. The board now includes three new members, increasing the female representation to 57%, well above the Swiss average. Özlem Civelek, Christoph Auchli, Susanne Ziegler, and Christian Reuss join the board, while Heeb, Maya Salzmann, and Christian Wunderlin step down.

ubs maintains buy rating for nordea bank ahead of quarterly results

UBS has maintained a "Buy" rating for Nordea Bank Abp, setting a target price of 150 Swedish kronor ahead of the bank's first quarter results due on April 16. Analyst Johan Ekblom anticipates a slight decline in net profit compared to the previous quarter, projecting a 19% drop year-on-year due to lower revenues, increased costs, and normalizing credit losses. He also notes that interest rate cuts will pose challenges to earnings, with deposit protection and currency effects insufficient to mitigate these pressures.

ubs maintains neutral rating for h&m after disappointing first quarter results

UBS has maintained a "Neutral" rating for H&M with a target price of 149 Swedish kronor following disappointing first-quarter results that missed expectations. Analyst Sreedhar Mahamkali noted that while the share price has weakened, it suggests that investor expectations have already adjusted downward, despite ongoing concerns about the operating result (EBIT).
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Machinary - Dashboard

Client connection lost

Please check your connection. We try to reconnect...

Server connection lost

If our server is updating to a new version, please wait a moment before the service is available again.

Connection refused

All connection attempts have been rejected. This is most likely due to network problems or server problems.